Medtronic’s Affinity Fusion Artificial Lungs for Bypass Surgeries

Medtronic received FDA clearance for its Affinity Fusion blood oxygenation/CO2 removal system for open heart surgeries. The new system was designed with particular engineering attention paid to reducing bubble formation and so preventing air embolisms.The Affinity Fusion was approved in Europe in September of last year and has already been used successfully in the U.S. at the Cleveland Clinic.Read More
Source: Medgadget Anesthesiology - Category: Anesthesiology Authors: Tags: Anesthesiology Cardiac Surgery Source Type: news

Related Links:

Publication date: June 2018Source: Anaesthesia &Intensive Care Medicine, Volume 19, Issue 6Author(s): Barbora Parizkova, Gavin WrightAbstractThe Registry of the International Society for Heart and Lung Transplantation reported 4196 heart transplants and 3812 lung transplants worldwide in 2015. The 100,000th heart transplant mark has been passed. Heart transplantation is a proven surgical option for selected patients who have advanced heart failure refractory to surgical or medical management. Lung transplantation is the definitive treatment for end-stage lung disease for patients who have failed medical therapy. More t...
Source: Anaesthesia and intensive care medicine - Category: Anesthesiology Source Type: research
The FDA today granted pre-market approval under its breakthrough devices designation to the Zephyr endobronchial valve made by Pulmonx for treating severe emphysema. Emphysema, a chronic obstructive pulmonary disease, causes irreversible damage to the lung’s alveoli, trapping air during exhalation that in turn can cause the diseased tissue to grow larger and pressure healthy lung tissue. The Zephyr device is designed to decrease the volume of the chest to improve function in the heart, respiratory muscles and healthy lung tissue. Inserted via bronchoscopy, the pencil-eraser-sized valves prevent air from ent...
Source: Mass Device - Category: Medical Devices Authors: Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Pulmonx Source Type: news
Rationale: Intrapleural hyperthermic chemotherapy (IPHC) is the preferred method to locally treat lung cancer with pleural seeding. Anesthetic management during IPHC is a very challenging task for the anesthesiologist because of the hemodynamic instability associated with the procedure; however, there is no report on anesthetic considerations during the IPHC procedure. Patient concerns: Three patients who diagnosed lung cancer with pleural invasion scheduled for IPHC were reported in this case series. Diagnosis: Case 1, a 48-year-old woman, suffered from lung cancer (adenocarcinoma, T2NxM1a) with diffuse pleural se...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
CONCLUSION: Due to the increasing number of patients on long-term mechanical circulatory support, the chances are that physicians in the initial emergency admission are unfamiliar with these devices but need to operate them in emergency cases. Therefore, knowledge of these procedures and their complications becomes increasingly important. PMID: 29623383 [PubMed - as supplied by publisher]
Source: Der Anaesthesist - Category: Anesthesiology Authors: Tags: Anaesthesist Source Type: research
Many deceased by neurologic criteria donors are administered inhalational agents during organ recovery surgery —a process that is characterised by warm and cold ischaemia followed by warm reperfusion. In certain settings, volatile anaesthetics (VA) are known to precondition organs to protect them from subsequent ischaemia–reperfusion injury. As such, we hypothesised that exposure to VA during organ procu rement would improve post-graft survival. Lifebanc (organ procurement organisation [OPO] for NE Ohio) provided the investigators with a list of death by neurologic criteria organ donors cared for at three large...
Source: Anaesthesia and Intensive Care - Category: Anesthesiology Source Type: research
WITH OVER 4,000 lung transplant cases performed each year, lung transplantation remains a critical therapy for patients with a wide variety of end-stage lung diseases.1 Although long-term survival after lung transplantation is inferior compared with other solid organ transplants, such as heart, kidney, and liver, it does prolong life expectancy with a median survival of 7.4 years and 4.6 years for double- and single-lung transplant, respectively.1
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Tags: Editorial Source Type: research
By ANISH KOKA, MD No one knows who Bennie Solis is anymore. He had the misfortune of being born in the early 1960s marked for death. He had a rare peculiar condition called biliary atresia – a disease defined by the absence of a conduit for bile to travel from his liver to his intestinal tract. Bile acid produced in the liver normally travels to the intestines much like water from a spring travels via ever larger channels to eventually empty into the ocean. Bile produced in the liver with no where to go dams up in the liver and starts to destroy it. That the liver is a hardy organ was a fact known to the ancient Gree...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Uncategorized Source Type: blogs
“For those of us involved in heart and heart-lung transplantation, it was quite an experience to suddenly encounter an emptiness in the thorax, where moments before, a heart had been actively beating. Even a hardened person would find it difficult to control one’s inner emotions. Was this an act of meddling with the divine?”
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Tags: Editorial Source Type: research
CONCLUSIONS RVOTO is an unusual, but possible cause of severe arterial hypotension during general anesthesia induction. TEE is useful for the evaluation of severely hypotensive patients who do not respond to routine treatment with fluids and vasoconstrictors.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
Publication date: Available online 9 August 2017 Source:Best Practice & Research Clinical Anaesthesiology Author(s): Vera von Dossow, Joseph Costa, Frank D'Ovidio, Nandor Marczin Transplantation is sadly a therapy to die for. The survival of the recipient with end stage heart or lung disease requires the demise of a human being via brain death or cessation of circulation with the most noblest final act of offering one’s organs to another. However, transplantation is constrained by severe hemodynamic, regulatory, inflammatory and metabolic stresses in the donor rendering the majority of offered organs unsuitable ...
Source: Best Practice and Research Clinical Anaesthesiology - Category: Anesthesiology Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | Heart | Heart Transplant | Lung Transplant